- Destiny Pharma Plc (DEST) has reported the interim results for 6 months ended 30 June 2019.
- The company reported a strong cash position with cash and term deposits of £9.1 million as at 30 June 2019 of as compared to £15.1 million as at 30 June 2018 and £12.1 million as at 31 December 2018.
- Reflecting an increased investment in clinical programmes, the company reported an expenditure of £1.7 million on R&D in the period as compared to £1.3 million during the half-year 2018 and £3.5 million of full-year 2018.
- On 23rd September 2019, at the time of writing, GMT 12:12 PM, DEST shares were trading at GBX 43.00, up by 2.50 points or 6.17 per cent against the previous day closing price.
With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities.
Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?
Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.
We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.